PONAZA : A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISIS
Clinical trial NCT03895671 · COMPLETED
Trial details
- NCT number
- NCT03895671
- Sponsor
- Versailles Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-19
- Primary completion
- 2025-08-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.